Long-term probucol treatment results in regression of xanthomas, but in progression of coronary atherosclerosis in a heterozygous patient with familial hypercholesterolemia
- 29 February 1996
- journal article
- case report
- Published by Elsevier in Atherosclerosis
- Vol. 120 (1-2) , 181-187
- https://doi.org/10.1016/0021-9150(95)05699-8
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Prevention of coronary heart disease in clinical practice: recommendations of the task force of the European Society of cardiology, European atherosclerosis Society and European society of HypertensionAtherosclerosis, 1994
- Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)JAMA, 1993
- Plasma high density lipoproteins. Metabolism and relationship to atherogenesis.Journal of Clinical Investigation, 1990
- Mechanisms of HDL reduction after probucol. Changes in HDL subfractions and increased reverse cholesteryl ester transfer.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989
- Beyond CholesterolNew England Journal of Medicine, 1989
- Effects of CS-514 on serum lipoprotein lipid and apolipoprotein levels in patients with familial hypercholesterolemiaMetabolism, 1987
- Effects of probucol on xanthomata regression in familial hypercholesterolemiaThe American Journal of Cardiology, 1986
- Achilles tendon thickness and ischemic heart disease in familial hypercholesterolemiaMetabolism, 1978
- ProbucolDrugs, 1978
- Discrimination of familial hypercholesterolemia and secondary hypercholesterolemia by achilles' tendon thicknessAtherosclerosis, 1977